These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21715437)

  • 21. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
    Takácová M; Nogová P; Hábeková M; Staneková D
    Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polymorphisms of chemokine receptor alleles influencing genetic susceptibility to HIV-1 infection in Mongolia population in China].
    Du Q; Wang F; Hong W; Liu M; Jin L; Shi H; Lei Z; E E
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):413-6. PubMed ID: 11860823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common CCR 5 polymorphism in stroke: the CCR 5 delta32 polymorphism differentiates cardioembolism from other aetiologies of ischaemic cerebrovascular diseases.
    Kostulas N; Markaki I; Kostulas V; Hillert J; Kostulas K
    Scand J Immunol; 2009 Nov; 70(5):475-80. PubMed ID: 19874552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
    Morawetz RA; Rizzardi GP; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser MP; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
    Eur J Immunol; 1997 Dec; 27(12):3223-7. PubMed ID: 9464809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression.
    Paxton WA; Kang S
    Semin Immunol; 1998 Jun; 10(3):187-94. PubMed ID: 9653045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
    Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
    Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to infectious disease.
    Segal S; Hill AV
    Trends Microbiol; 2003 Sep; 11(9):445-8. PubMed ID: 13678861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy.
    Guerini FR; Delbue S; Zanzottera M; Agliardi C; Saresella M; Mancuso R; Maserati R; Marchioni E; Gori A; Ferrante P
    Biomed Pharmacother; 2008 Jan; 62(1):26-30. PubMed ID: 17560067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of genetic variations in C-C chemokine receptors and ligands on infectious diseases.
    Qidwai T; Khan MY
    Hum Immunol; 2016 Oct; 77(10):961-971. PubMed ID: 27316325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible mechanism for the generation of the HIV-1-resistant form of the CCR5 delta32 mutant chemokine receptor.
    Faulds D; Horuk R
    Curr Biol; 1997 Sep; 7(9):R529-30. PubMed ID: 9285728
    [No Abstract]   [Full Text] [Related]  

  • 37. CCR5 Promoter Polymorphism -2459G > A: Forgotten or Ignored?
    Mehlotra RK
    Cells; 2019 Jun; 8(7):. PubMed ID: 31261839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCR5 chemokine receptor polymorphism in patients with HIV-1 from Western India.
    Shankarkumar A; Shankarkumar U; Ghosh K
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):e21. PubMed ID: 21709449
    [No Abstract]   [Full Text] [Related]  

  • 39. Balanced polymorphism selected by genetic versus infectious human disease.
    Dean M; Carrington M; O'Brien SJ
    Annu Rev Genomics Hum Genet; 2002; 3():263-92. PubMed ID: 12142357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Review of the relationship between human TLR9 gene polymorphisms and infectious diseases].
    Cheng RD; Wang ZX
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):946-8. PubMed ID: 24495770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.